Qianqian Xu
Hangzhou, 310018, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Tanshinone I as a novel ferritinophagy inducer triggers ferroptosis to suppress gastric cancer growth.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 11, 2026
Functional Suppression of SCAP Triggers Endoplasmic Reticulum Stress-Dependent Ferroptosis by Impairing Cholesterol Metabolism in Gastric Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 05, 2026
MTSS1-dependent ubiquitin modifications mediated by FBXO44 remodel the actin cytoskeleton to promote gastric cancer progression.
Journal: Molecular cancer
Published: September 17, 2025
Enhancing platinum-based chemotherapy efficacy and safety through combination therapy-mediated remodeling of autophagic homeostasis in gastric cancer.
Journal: Cell death & disease
Published: June 23, 2025
Metabolomics reveals the implication of acetoacetate and ketogenic diet therapy in radioiodine-refractory differentiated thyroid carcinoma.
Journal: The oncologist
Published: January 05, 2024
Combined BRAF and PIM1 inhibitory therapy for papillary thyroid carcinoma based on BRAFV600E regulation of PIM1: Synergistic effect and metabolic mechanisms.
Journal: Neoplasia (New York, N.Y.)
Published: January 04, 2024
Abnormal arginine synthesis confers worse prognosis in patients with middle third gastric cancer.
Journal: Cancer cell international
Published: September 08, 2023
Platycodin-D exerts its anti-cancer effect by promoting c-Myc protein ubiquitination and degradation in gastric cancer.
Journal: Frontiers in pharmacology
Published: January 06, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026